Publications
-
Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR).
Abbasi F,
Okeke Q, Reaven GM.
Acta Diabetol.
2013
-
Is measurement of non-HDL cholesterol an effective way to identify the metabolic syndrome?
Liu A,
Reaven GM.
Nutr Metab Cardiovasc Dis.
2013
-
Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp.
Knowles JW,
Assimes TL, Tsao PS, Natali A, Mari A, Quertermous T, Reaven GM, Abbasi F.
Metabolism.
2013;
62
(4):
548-53
-
Risk for obstructive sleep apnea in obese, nondiabetic adults varies with insulin resistance status.
Liu A,
Kushida CA, Reaven GM.
Sleep Breath.
2013;
17
(1):
333-8
-
Body mass index and waist circumference associate to a comparable degree with insulin resistance and related metabolic abnormalities in South Asian women and men.
Abbasi F,
Malhotra D, Mathur A, Reaven GM, Molina CR.
Diab Vasc Dis Res.
2012;
9
(4):
296-300
-
Relations between obesity, insulin resistance, and 25-hydroxyvitamin D.
Lamendola CA,
Ariel D, Feldman D, Reaven GM.
Am J Clin Nutr.
2012;
95
(5):
1055-9
-
Adiposity indices in the prediction of metabolic abnormalities associated with cardiovascular disease in non-diabetic adults.
Liu A,
Abbasi F, Reaven GM.
Nutr Metab Cardiovasc Dis.
2011;
21
(8):
553-60
-
Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.
Yue P,
Jin H, Xu S, Aillaud M, Deng AC, Azuma J, Kundu RK, Reaven GM, Quertermous T, Tsao PS.
Endocrinology.
2011;
152
(1):
59-68
-
Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol.
Abbasi F,
Reaven GM.
Metabolism.
2011;
60
(12):
1673-6
-
Estimates of insulin secretory function in apparently healthy volunteers vary as a function of how the relevant variables are quantified.
Johns BR,
Abbasi F, Reaven GM.
Clin Chem.
2011;
57
(4):
627-32
-
Insulin resistance: from bit player to centre stage.
Reaven GM,
CMAJ.
2011;
183
(5):
536-7
-
Insulin resistance: the link between obesity and cardiovascular disease.
Reaven GM,
Med Clin North Am.
2011;
95
(5):
875-92
-
Plasma glucose and insulin responses to mixed meals: impaired fasting glucose re-visited.
Bhat S,
Abbasi F, Blasey C, Reaven G, Kim Sh.
Diab Vasc Dis Res.
2011;
8
(4):
271-5
-
Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences.
Reaven GM,
J Clin Hypertens (Greenwich).
2011;
13
(4):
238-43
-
The metabolic syndrome: time to get off the merry-go-round?
Reaven GM,
J Intern Med.
2011;
269
(2):
127-36
-
What is the effect of rosiglitazone treatment on insulin secretory function in insulin-resistant individuals? It depends on how you measure it.
Abbasi F,
Lamendola C, Reaven GM.
Metabolism.
2011;
60
(1):
57-62
-
Apelin is necessary for the maintenance of insulin sensitivity.
Yue P,
Jin H, Aillaud M, Deng AC, Azuma J, Asagami T, Kundu RK, Reaven GM, Quertermous T, Tsao PS.
Am J Physiol Endocrinol Metab.
2010;
298
(1):
E59-67
-
Glucose-stimulated insulin secretion in gastric bypass patients with hypoglycemic syndrome: no evidence for inappropriate pancreatic beta-cell function.
Kim SH,
Abbasi F, Lamendola C, Reaven GM, McLaughlin T.
Obes Surg.
2010;
20
(8):
1110-6
-
Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue.
McLaughlin TM,
Liu T, Yee G, Abbasi F, Lamendola C, Reaven GM, Tsao P, Cushman SW, Sherman A.
Obesity (Silver Spring).
2010;
18
(5):
926-31
-
Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents.
Kim SH,
Nikolics L, Abbasi F, Lamendola C, Link J, Reaven GM, Lindley S.
J Psychiatr Res.
2010;
44
(8):
493-8
-
Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats.
Dhalla AK,
Santikul M, Chisholm JW, Belardinelli L, Reaven GM.
Diabetes Obes Metab.
2009;
11
(2):
95-101
-
Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women.
Liu A,
McLaughlin T, Liu T, Sherman A, Yee G, Abbasi F, Lamendola C, Morton J, Cushman SW, Reaven GM, Tsao PS.
Obes Surg.
2009;
19
(11):
1564-73
-
HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not?
Reaven GM,
Diab Vasc Dis Res.
2009;
6
(2):
133-8
-
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment.
Reaven GM,
Lieberman JA, Sethuraman G, Kraemer H, Davis JM, Blasey C, Tsuang MT, Schatzberg AF.
J Psychiatr Res.
2009;
43
(11):
997-1002
-
Insulin resistance in pulmonary arterial hypertension.
Zamanian RT,
Hansmann G, Snook S, Lilienfeld D, Rappaport KM, Reaven GM, Rabinovitch M, Doyle RL.
Eur Respir J.
2009;
33
(2):
318-24
-
Insulin secretory function in type 2 diabetes: Does it matter how you measure it?
Reaven GM,
J Diabetes.
2009;
1
(3):
142-50
-
Is diagnosing metabolic syndrome a uniquely simple way to predict incident type 2 diabetes mellitus?
Reaven GM,
CMAJ.
2009;
180
(6):
601-2
-
Pioglitazone decreases postprandial accumulation of remnant lipoproteins in insulin-resistant smokers.
Abbasi F,
Lamendola C, Leary ET, Reaven GM.
Diabetes Obes Metab.
2009;
11
(8):
779-85
-
Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia.
Kim SH,
Liu TC, Abbasi F, Lamendola C, Morton JM, Reaven GM, McLaughlin TL.
Obes Surg.
2009;
19
(11):
1550-6
-
Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension.
Lima NK,
Abbasi F, Lamendola C, Reaven GM.
Am J Hypertens.
2009;
22
(1):
106-11
-
Comparison of three treatment approaches to decreasing cardiovascular disease risk in nondiabetic insulin-resistant dyslipidemic subjects.
Abbasi F,
Chen YD, Farin HM, Lamendola C, Reaven GM.
Am J Cardiol.
2008;
102
(1):
64-9
-
Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease.
Ryan MC,
Fenster Farin HM, Abbasi F, Reaven GM.
Am J Cardiol.
2008;
102
(1):
40-6
-
Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?
Li C,
Ford ES, Meng YX, Mokdad AH, Reaven GM.
Cardiovasc Diabetol.
2008:
7
4
-
Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women.
Martin M,
Palaniappan LP, Kwan AC, Reaven GM, Reaven PD.
Diabetes Care.
2008;
31
(4):
798-801
-
Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis.
Galluccio E,
Piatti P, Citterio L, Lucotti PC, Setola E, Cassina L, Oldani M, Zavaroni I, Bosi E, Colombo A, Alfieri O, Casari G, Reaven GM, Monti LD.
Am J Physiol Endocrinol Metab.
2008;
294
(5):
E978-86
-
Insulin resistance and hyperinsulinemia: you can't have one without the other.
Kim SH,
Reaven GM.
Diabetes Care.
2008;
31
(7):
1433-8
-
Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship.
Kim SH,
Reaven GM.
Diabetes Care.
2008;
31
(2):
347-52
-
Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women?
Alhassan S,
Kiazand A, Balise RR, King AC, Reaven GM, Gardner CD.
Metabolism.
2008;
57
(1):
49-56
-
Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers.
Abbasi F,
Farin HM, Lamendola C, McGraw L, McLaughlin T, Reaven GM.
Metabolism.
2008;
57
(8):
1108-14
-
A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents.
Dhalla AK,
Wong MY, Voshol PJ, Belardinelli L, Reaven GM.
Am J Physiol Endocrinol Metab.
2007;
292
(5):
E1358-63
-
ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.
Ardigo D,
Stüehlinger M, Franzini L, Valtueña S, Piatti PM, Pachinger O, Reaven GM, Zavaroni I.
Eur J Clin Invest.
2007;
37
(4):
263-9
-
Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis.
McLaughlin T,
Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C, Reaven GM, Cushman SW.
Diabetologia.
2007;
50
(8):
1707-15
-
HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes.
Glassford AJ,
Yue P, Sheikh AY, Chun HJ, Zarafshar S, Chan DA, Reaven GM, Quertermous T, Tsao PS.
Am J Physiol Endocrinol Metab.
2007;
293
(6):
E1590-6
-
Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
Palaniappan LP,
Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM.
Metabolism.
2007;
56
(7):
899-904
-
Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.
Kim SH,
Ivanova O, Abbasi FA, Lamendola CA, Reaven GM, Glick ID.
J Clin Psychopharmacol.
2007;
27
(4):
365-8
-
Relationship among alcohol, body weight, and cardiovascular risk factors in 27,030 Korean men.
Sung KC,
Kim SH, Reaven GM.
Diabetes Care.
2007;
30
(10):
2690-4
-
Relationship between obesity and several cardiovascular disease risk factors in apparently healthy Korean individuals: comparison of body mass index and waist circumference.
Sung KC,
Ryu S, Reaven GM.
Metabolism.
2007;
56
(3):
297-303
-
Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
Sung KC,
Ryan MC, Kim BS, Cho YK, Kim BI, Reaven GM.
Diabetes Care.
2007;
30
(8):
2113-8
-
The individual components of the metabolic syndrome: is there a raison d'etre?
Reaven GM,
J Am Coll Nutr.
2007;
26
(3):
191-5
-
The relationship between insulin resistance and dyslipidaemia in cigarette smokers.
Farin HM,
Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM.
Diabetes Obes Metab.
2007;
9
(1):
65-9
-
Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults.
Farin HM,
Abbasi F, Reaven GM.
Am J Clin Nutr.
2006;
83
(1):
47-51
-
Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals.
Farin HM,
Abbasi F, Reaven GM.
Am J Cardiol.
2006;
98
(8):
1053-6
-
Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH,
Chunawala L, Linde R, Reaven GM.
J Am Coll Cardiol.
2006;
48
(2):
293-7
-
Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes.
Abbasi F,
Chang SA, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, Reaven GM, Reaven PD.
Am J Physiol Regul Integr Comp Physiol.
2006;
290
(1):
R139-44
-
Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension.
Zavaroni I,
Ardigò D, Zuccarelli A, Pacetti E, Piatti PM, Monti L, Valtueña S, Massironi P, Rossi PC, Reaven GM.
Nutr Metab Cardiovasc Dis.
2006;
16
(1):
22-7
-
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
Cataldo NA,
Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM.
Hum Reprod.
2006;
21
(1):
109-20
-
Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss.
McLaughlin T,
Stühlinger M, Lamendola C, Abbasi F, Bialek J, Reaven GM, Tsao PS.
J Clin Endocrinol Metab.
2006;
91
(5):
1896-900
-
Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers.
Ardigo D,
Franzini L, Valtuena S, Monti LD, Reaven GM, Zavaroni I.
Am J Cardiol.
2006;
97
(8):
1250-4
-
The metabolic syndrome: is this diagnosis necessary?
Reaven GM,
Am J Clin Nutr.
2006;
83
(6):
1237-47
-
The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers.
Abbasi F,
Farin HM, Lamendola C, McLaughlin T, Schwartz EA, Reaven GM, Reaven PD.
J Clin Endocrinol Metab.
2006;
91
(12):
5002-7
-
Trends in hyperinsulinemia among nondiabetic adults in the U.S.
Li C,
Ford ES, McGuire LC, Mokdad AH, Little RR, Reaven GM.
Diabetes Care.
2006;
29
(11):
2396-402
-
Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake.
Farin HM,
Abbasi F, Reaven GM.
Metabolism.
2005;
54
(10):
1323-8
-
Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals.
Reaven GM,
Endocrinol Metab Clin North Am.
2005;
34
(1):
49-62
-
Effect of a high-carbohydrate versus a high--cis-monounsaturated fat diet on blood pressure in patients with type 2 diabetes.
Shah M,
Adams-Huet B, Bantle JP, Henry RR, Griver KA, Raatz SK, Brinkley LJ, Reaven GM, Garg A.
Diabetes Care.
2005;
28
(11):
2607-12
-
Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects.
Chu JW,
Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Tsao PS.
Diab Vasc Dis Res.
2005;
2
(1):
37-41
-
Hemostatic abnormalities associated with obesity and the metabolic syndrome.
Reaven GM,
Scott EM, Grant PJ, Lowe GD, Rumley A, Wannamethee SG, Stratmann B, Tschoepe D, Blann A, Juhan-Vague I, Alessi MC, Bailey C.
J Thromb Haemost.
2005;
3
(5):
1074-85
-
Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.
Ardigò D,
Numeroso F, Valtueña S, Franzini L, Piatti PM, Monti L, Delsignore R, Reaven GM, Zavaroni I.
Metabolism.
2005;
54
(12):
1566-70
-
Increased aortic stiffness in the insulin-resistant Zucker fa/fa rat.
Sista AK,
O'Connell MK, Hinohara T, Oommen SS, Fenster BE, Glassford AJ, Schwartz EA, Taylor CA, Reaven GM, Tsao PS.
Am J Physiol Heart Circ Physiol.
2005;
289
(2):
H845-51
-
Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose.
Ford ES,
Abbasi F, Reaven GM.
Atherosclerosis.
2005;
181
(1):
143-8
-
Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.
Kim SH,
Abbasi F, Chu JW, McLaughlin TL, Lamendola C, Polonsky KS, Reaven GM.
Diabetes.
2005;
54
(8):
2447-52
-
The insulin resistance syndrome: definition and dietary approaches to treatment.
Reaven GM,
Annu Rev Nutr.
2005:
25
391-406
-
The metabolic syndrome: requiescat in pace.
Reaven GM,
Clin Chem.
2005;
51
(6):
931-8
-
Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome.
Reaven GM,
Cell Metab.
2005;
1
(1):
9-14
-
Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients.
Beatty G,
Chu J, Kulkarni K, Lipshutz G, Khalili M, Abbasi F, Stansell J, Reaven GM.
HIV Clin Trials.
2004 Nov-Dec;
5
(6):
383-91
-
Discrimination between obesity and insulin resistance in the relationship with adiponectin.
Abbasi F,
Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD.
Diabetes.
2004;
53
(3):
585-90
-
Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.
Abbasi F,
Chu JW, McLaughlin T, Lamendola C, Leary ET, Reaven GM.
Metabolism.
2004;
53
(2):
159-64
-
Impact of degree of obesity on surrogate estimates of insulin resistance.
Kim SH,
Abbasi F, Reaven GM.
Diabetes Care.
2004;
27
(8):
1998-2002
-
Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link.
Witteles RM,
Tang WH, Jamali AH, Chu JW, Reaven GM, Fowler MB.
J Am Coll Cardiol.
2004;
44
(1):
78-81
-
Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit?
Reaven GM,
Diabetes Care.
2004;
27
(4):
1011-2
-
Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women.
Abbasi F,
Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD.
Metabolism.
2004;
53
(3):
280-3
-
Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension.
Zavaroni I,
Ardigo D, Rossi PC, Zuccarelli A, Pacetti E, Monti L, Piatti PM, Reaven GM.
Am J Hypertens.
2004;
17
(7):
549-52
-
Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome.
Cheal KL,
Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES.
Diabetes.
2004;
53
(5):
1195-200
-
The metabolic syndrome: one step forward, two steps back.
Kim SH,
Reaven GM.
Diab Vasc Dis Res.
2004;
1
(2):
68-75
-
American College of Endocrinology position statement on the insulin resistance syndrome.
Einhorn D,
Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW.
Endocr Pract.
2003 May-Jun;
9
(3):
237-52
-
A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential.
Dey D,
Medicherla S, Neogi P, Gowri M, Cheng J, Gross C, Sharma SD, Reaven GM, Nag B.
Metabolism.
2003;
52
(8):
1012-8
-
Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance.
McLaughlin TL,
Reaven GM.
Am J Med.
2003;
114
(6):
501-2
-
Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia.
Lucas CP,
Boldrin MN, Reaven GM.
Am J Cardiol.
2003;
91
(8):
961-4
-
Importance of identifying the overweight patient who will benefit the most by losing weight.
Reaven GM,
Ann Intern Med.
2003;
138
(5):
420-3
-
Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease.
Reaven GM,
J Clin Endocrinol Metab.
2003;
88
(6):
2399-403
-
Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents.
Chu JW,
Abbasi F, McLaughlin TL, Lamendola C, Schaaf P, Carlson TH, Leary ET, Reaven GM.
Diabetes Obes Metab.
2003;
5
(5):
333-7
-
Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients.
Chu JW,
Abbasi F, Beatty GW, Khalili M, Koch J, Rosen A, Schmidt JM, Stansell JD, Reaven GM.
Metabolism.
2003;
52
(7):
858-61
-
Multiple lipoprotein abnormalities associated with insulin resistance in healthy volunteers are identified by the vertical auto profile-II methodology.
Chu JW,
Abbasi F, Kulkarni KR, Lamendola C, McLaughlin TL, Scalisi JN, Reaven GM.
Clin Chem.
2003;
49
(6 Pt 1):
1014-7
-
Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors.
Beatty G,
Khalili M, Abbasi F, Chu J, Reaven GM, Rosen A, Schmidt JM, Stansell J, Koch J.
J Acquir Immune Defic Syndr.
2003;
33
(1):
34-40
-
The insulin resistance syndrome.
Reaven GM,
Curr Atheroscler Rep.
2003;
5
(5):
364-71
-
What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?
Zavaroni I,
Numeroso F, Dongiovanni P, Ardigò D, Valenti L, Fracanzani Al, Valtuena S, Delsignore R, Fargion S, Reaven GM.
Metabolism.
2003;
52
(12):
1593-6
-
Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl-coenzyme a reductase inhibitor treatment of combined dyslipidemia.
McLaughlin T,
Abbasi F, Lamendola C, Leary E, Reaven GM.
Metabolism.
2002;
51
(10):
1355-9
-
Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans.
Abbasi F,
Reaven GM.
Metabolism.
2002;
51
(2):
235-7
-
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
Lin KY,
Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP.
Circulation.
2002;
106
(8):
987-92
-
Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes.
Asagami T,
Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP, Reaven GM, Tsao PS.
Metabolism.
2002;
51
(7):
843-6
-
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
Reaven GM,
Diabetes Obes Metab.
2002:
4 Suppl 1
S13-8
-
Preferential involvement of larger vessels in a rat model of diabetes-induced graft vasculopathy.
Cantin B,
Zhu D, Wen P, Panchal SN, Gwathmey JK, Reaven GM, Valantine HA.
J Heart Lung Transplant.
2002;
21
(9):
1040-3
-
Relationship between fasting and day-long plasma glucose concentrations in diet-treated patients with type 2 diabetes.
Abbasi F,
Reaven GM.
Metabolism.
2002;
51
(4):
457-9
-
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Stühlinger MC,
Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS.
JAMA.
2002;
287
(11):
1420-6
-
Relationship between obesity, insulin resistance, and coronary heart disease risk.
Abbasi F,
Brown BW, Lamendola C, McLaughlin T, Reaven GM.
J Am Coll Cardiol.
2002;
40
(5):
937-43
-
Relative impact of low-density lipoprotein-cholesterol concentration and insulin resistance on carotid wall thickening in nondiabetic, normotensive volunteers.
Wang PW,
Liou CW, Wang ST, Eng HL, Liu RT, Tung SC, Chien WY, Lu YC, Kuo MC, Hsieh CJ, Chen CH, Chen JF, Chu JW, Reaven GM.
Metabolism.
2002;
51
(2):
255-9
-
Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin.
Cantin B,
Zhu D, Wen P, Panchal SN, Dai X, Gwathmey JK, Reaven GM, Valantine HA.
J Heart Lung Transplant.
2002;
21
(6):
637-43
-
Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women.
Kim HS,
Abbasi F, Lamendola C, McLaughlin T, Reaven GM.
Am J Clin Nutr.
2001;
74
(5):
592-5
-
Familial factors in the antihypertensive response to lisinopril.
Hollenberg NK,
Anzalone DA, Falkner B, Fisher ND, Hopkins PN, Hsueh W, Hutchinson H, Krauss RM, Price DA, Raskin P, Reaven GM.
Am J Hypertens.
2001;
14
(3):
218-23
-
Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone.
Cataldo NA,
Abbasi F, McLaughlin TL, Lamendola C, Reaven GM.
Fertil Steril.
2001;
76
(5):
1057-9
-
Insulin resistance as a predictor of age-related diseases.
Facchini FS,
Hua N, Abbasi F, Reaven GM.
J Clin Endocrinol Metab.
2001;
86
(8):
3574-8
-
Insulin resistance, dietary cholesterol, and cholesterol concentration in postmenopausal women.
Reaven GM,
Abbasi F, Bernhart S, Coulston A, Darnell B, Dashti N, Kim H, Kulkarni K, Lamendola C, McLaughlin T, Osterlund L, Schaff P, Segrest J.
Metabolism.
2001;
50
(5):
594-7
-
Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
McLaughlin T,
Abbasi F, Lamendola C, Kim HS, Reaven GM.
Metabolism.
2001;
50
(7):
819-24
-
Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.
Abbasi F,
Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuehlinger M, Tsao PS.
Am J Cardiol.
2001;
88
(10):
1201-3
-
Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes.
Ai M,
Tanaka A, Ogita K, Sekinc M, Numano F, Numano F, Reaven GM.
J Am Coll Cardiol.
2001;
38
(6):
1628-32
-
Why is it important to be insulin sensitive?
Reaven GM,
Diabetes Metab.
2001;
27
(2 Pt 2):
189-92
-
[Insulin resistance: why is it important to treat?].
Reaven GM,
Diabetes Metab.
2001;
27
(2 Pt 2):
247-53
-
A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
Reed MJ,
Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM.
Metabolism.
2000;
49
(11):
1390-4
-
Are the results really different?
Reaven GM,
Diabetes Care.
2000;
23
(7):
1040
-
Comparison of fasting plasma leptin concentrations in healthy subjects with high and low plasma insulin.
Zavaroni I,
Gasparini P, Barilli AI, Massironi P, Campanini C, Carantoni M, Delsignore R, Reaven GM.
Metabolism.
2000;
49
(4):
499-502
-
Diet and Syndrome X.
Reaven GM,
Curr Atheroscler Rep.
2000;
2
(6):
503-7
-
Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic control.
Santos RF,
Nomizo R, Oliveira E, Ursich M, Wajchenberg B, Reaven GM, Azhar S.
Diabetes Obes Metab.
2000;
2
(4):
237-41
-
High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk.
Abbasi F,
McLaughlin T, Lamendola C, Kim HS, Tanaka A, Wang T, Nakajima K, Reaven GM.
Am J Cardiol.
2000;
85
(1):
45-8
-
Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?
Facchini FS,
Hua NW, Reaven GM, Stoohs RA.
Free Radic Biol Med.
2000;
29
(12):
1302-6
-
Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance.
Abbasi F,
McLaughlin T, Lamendola C, Reaven GM.
Metabolism.
2000;
49
(2):
151-4
-
Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations.
Rosolová H,
Mayer O, Reaven GM.
Metabolism.
2000;
49
(3):
418-20
-
Masoprocol decreases rat lipolytic activity by decreasing the phosphorylation of HSL.
Gowri MS,
Azhar RK, Kraemer FB, Reaven GM, Azhar S.
Am J Physiol Endocrinol Metab.
2000;
279
(3):
E593-600
-
Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia.
Scribner KA,
Gadbois TM, Gowri M, Azhar S, Reaven GM.
Metabolism.
2000;
49
(9):
1106-10
-
Plasma insulin concentration is more tightly linked to plasma leptin concentration than is the body mass index.
Abbasi F,
Carantoni M, McLaughlin T, Reaven GM.
Metabolism.
2000;
49
(4):
544-7
-
Plasma nitric oxide concentrations are elevated in insulin-resistant healthy subjects.
Zavaroni I,
Platti PM, Monti LD, Gasparini P, Barilli LA, Massironi P, Ardigo D, Valsecchi G, Delsignore R, Reaven GM.
Metabolism.
2000;
49
(8):
959-61
-
Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols.
Facchini FS,
Humphreys MH, DoNascimento CA, Abbasi F, Reaven GM.
Am J Clin Nutr.
2000;
72
(3):
776-9
-
Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance.
Ai M,
Tanaka A, Ogita K, Sekine M, Numano F, Numano F, Reaven GM.
J Clin Endocrinol Metab.
2000;
85
(10):
3557-60
-
Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.
Yeni-Komshian H,
Carantoni M, Abbasi F, Reaven GM.
Diabetes Care.
2000;
23
(2):
171-5
-
Roles of insulin resistance and obesity in regulation of plasma insulin concentrations.
Jones CN,
Abbasi F, Carantoni M, Polonsky KS, Reaven GM.
Am J Physiol Endocrinol Metab.
2000;
278
(3):
E501-8
-
The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers.
Abbasi F,
McLaughlin T, Lamendola C, Reaven GM.
J Clin Endocrinol Metab.
2000;
85
(3):
1251-4
-
The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers.
Chen NG,
Azhar S, Abbasi F, Carantoni M, Reaven GM.
Atherosclerosis.
2000;
152
(1):
203-8
-
Blood pressure, sodium intake, insulin resistance, and urinary nitrate excretion.
Facchini FS,
DoNascimento C, Reaven GM, Yip JW, Ni XP, Humphreys MH.
Hypertension.
1999;
33
(4):
1008-12
-
Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?
Carantoni M,
Abbasi F, Azhar S, Schaaf P, Reaven GM.
J Clin Endocrinol Metab.
1999;
84
(3):
869-72
-
Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women.
Abbasi F,
McLaughlin T, Lamendola C, Lipinska I, Tofler G, Reaven GM.
Arterioscler Thromb Vasc Biol.
1999;
19
(11):
2818-21
-
Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ,
Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Brignetti D, Luo J, Khandwala A, Reaven GM.
Diabetologia.
1999;
42
(1):
102-6
-
Effect of masoprocol on glucose transport and lipolysis by isolated rat adipocytes.
Gowri MS,
Reaven GM, Azhar S.
Metabolism.
1999;
48
(4):
411-4
-
Enhanced monocyte adherence to thoracic aortae from rats with two forms of experimental hypertension.
Asagami T,
Reaven GM, Tsao PS.
Am J Hypertens.
1999;
12
(9 Pt 1):
890-3
-
Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers.
Abbasi F,
McLaughlin T, Lamendola C, Yeni-Komshian H, Tanaka A, Wang T, Nakajima K, Reaven GM.
J Clin Endocrinol Metab.
1999;
84
(11):
3903-6
-
Fatty acid inhibition of glucose-stimulated insulin secretion is enhanced in pancreatic islets from insulin-resistant rats.
Chen NG,
Reaven GM.
Metabolism.
1999;
48
(10):
1314-7
-
Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited.
Zavaroni I,
Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall'Aglio E, Delsignore R, Reaven GM.
Metabolism.
1999;
48
(8):
989-94
-
Insulin resistance, the key to survival: a rose by any other name.
Reaven GM,
Diabetologia.
1999;
42
(3):
384-5
-
Insulin resistance: a chicken that has come to roost.
Reaven GM,
Ann N Y Acad Sci.
1999:
892
45-57
-
Intensive blood pressure/glucose control in type 2 diabetes: why is it so difficult to decrease coronary heart disease?
Reaven GM,
J Hum Hypertens.
1999:
13 Suppl 2
S19-23; discussion S25-8
-
Masoprocol lowers blood pressure in rats with fructose-induced hypertension.
Gowri MS,
Reaven GM, Azhar S.
Am J Hypertens.
1999;
12
(7):
744-6
-
Measurements of insulin-mediated glucose disposal are stable over time.
Facchini F,
Humphreys MH, Jeppesen J, Reaven GM.
J Clin Endocrinol Metab.
1999;
84
(5):
1567-9
-
Metformin treatment leads to an increase in basal, but not insulin-stimulated, glucose disposal in obese patients with impaired glucose tolerance.
Morel Y,
Golay A, Perneger T, Lehmann T, Vadas L, Pasik C, Reaven GM.
Diabet Med.
1999;
16
(8):
650-5
-
Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers.
Chen NG,
Abbasi F, Lamendola C, McLaughlin T, Cooke JP, Tsao PS, Reaven GM.
Circulation.
1999;
100
(9):
940-3
-
Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes.
Luo J,
Cheung J, Yevich EM, Clark JP, Tsai J, Lapresca P, Ubillas RP, Fort DM, Carlson TJ, Hector RF, King SR, Mendez CD, Jolad SD, Reaven GM.
J Pharmacol Exp Ther.
1999;
288
(2):
529-34
-
PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression.
Chen NG,
Sarabia SF, Malloy PJ, Zhao XY, Feldman D, Reaven GM.
Biochem Biophys Res Commun.
1999;
263
(3):
718-22
-
Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal.
Abbasi F,
Facchini F, Humphreys MH, Reaven GM.
Atherosclerosis.
1999;
146
(1):
175-8
-
Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers.
Chen NG,
Holmes M, Reaven GM.
J Clin Endocrinol Metab.
1999;
84
(10):
3485-9
-
Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta.
Bierer DE,
Dubenko LG, Zhang P, Lu Q, Imbach PA, Garofalo AW, Phuan PW, Fort DM, Litvak J, Gerber RE, Sloan B, Luo J, Cooper R, Reaven GM.
J Med Chem.
1998;
41
(15):
2754-64
-
Can weight gain in healthy, nonobese volunteers be predicted by differences in baseline plasma insulin concentration?
Zavaroni I,
Zuccarelli A, Gasparini P, Massironi P, Barilli A, Reaven GM.
J Clin Endocrinol Metab.
1998;
83
(10):
3498-500
-
Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent.
Luo J,
Fort DM, Carlson TJ, Noamesi BK, nii-Amon-Kotei D, King SR, Tsai J, Quan J, Hobensack C, Lapresca P, Waldeck N, Mendez CD, Jolad SD, Bierer DE, Reaven GM.
Diabet Med.
1998;
15
(5):
367-74
-
Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin.
Abbasi F,
Carantoni M, Chen YD, Reaven GM.
Diabetes Care.
1998;
21
(8):
1301-5
-
Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women.
Facchini FS,
Carantoni M, Jeppesen J, Reaven GM.
Metabolism.
1998;
47
(7):
831-5
-
Hypothesis: muscle insulin resistance is the ("not-so") thrifty genotype.
Reaven GM,
Diabetologia.
1998;
41
(4):
482-4
-
Individuals with high total cholesterol/HDL cholesterol ratios are insulin resistant.
Jeppesen J,
Facchini FS, Reaven GM.
J Intern Med.
1998;
243
(4):
293-8
-
Insulin resistance and human disease: a short history.
Reaven GM,
J Basic Clin Physiol Pharmacol.
1998;
9
(2-4):
387-406
-
Insulin resistance may or may not play a role in blood pressure regulation.
Reaven GM,
J Intern Med.
1998;
244
(4):
359-60
-
Insulin resistance may or may not play a role in blood pressure regulation.
Reaven GM,
J Intern Med.
1998;
244
(4):
359-60
-
Interaction of diabetes and hypertension on determinants of endothelial adhesiveness.
Tsao PS,
Niebauer J, Buitrago R, Lin PS, Wang BY, Cooke JP, Chen YD, Reaven GM.
Arterioscler Thromb Vasc Biol.
1998;
18
(6):
947-53
-
Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata).
Luo J,
Chuang T, Cheung J, Quan J, Tsai J, Sullivan C, Hector RF, Reed MJ, Meszaros K, King SR, Carlson TJ, Reaven GM.
Eur J Pharmacol.
1998;
346
(1):
77-9
-
Nongenetic mouse models of non-insulin-dependent diabetes mellitus.
Luo J,
Quan J, Tsai J, Hobensack CK, Sullivan C, Hector R, Reaven GM.
Metabolism.
1998;
47
(6):
663-8
-
Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance.
Carantoni M,
Abbasi F, Azhar S, Chen YD, Klebanov M, Wang PW, Warmerdam F, Reaven GM.
Diabetes.
1998;
47
(2):
244-7
-
Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers.
Carantoni M,
Abbasi F, Warmerdam F, Klebanov M, Wang PW, Chen YD, Azhar S, Reaven GM.
Arterioscler Thromb Vasc Biol.
1998;
18
(5):
762-7
-
Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease.
Yip J,
Facchini FS, Reaven GM.
J Clin Endocrinol Metab.
1998;
83
(8):
2773-6
-
Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM.
Carantoni M,
Abbasi F, Chu L, Chen YD, Reaven GM, Tsao PS, Varasteh B, Cooke JP.
Diabetes Care.
1997;
20
(9):
1462-5
-
Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.
Jones CN,
Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM.
J Clin Endocrinol Metab.
1997;
82
(6):
1834-8
-
Banting Lecture 1988. Role of insulin resistance in human disease. 1988.
Reaven GM,
Nutrition.
1997;
13
(1):
65; discussion 64, 66
-
Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against.
Reaven GM,
Curr Opin Lipidol.
1997;
8
(1):
23-7
-
Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance.
Santos RF,
Nomizo R, Bopsco A, Wajchenberg BL, Reaven GM, Azhar S.
Diabetes Metab.
1997;
23
(2):
143-8
-
Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
Kamath V,
Jones CN, Yip JC, Varasteh BB, Cincotta AH, Reaven GM, Chen YD.
Diabetes Care.
1997;
20
(11):
1697-701
-
Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women.
Jeppesen J,
Schaaf P, Jones C, Zhou MY, Chen YD, Reaven GM.
Am J Clin Nutr.
1997;
65
(4):
1027-33
-
Ethnic differences in insulin resistance and its consequences in older Mexican American and non-Hispanic white women.
Aguirre MA,
Jones CN, Pei D, Villa ML, Reaven GM.
J Gerontol A Biol Sci Med Sci.
1997;
52
(1):
M56-60
-
Evidence that insulin can directly inhibit hepatic glucose production.
Maheux P,
Chen YD, Polonsky KS, Reaven GM.
Diabetologia.
1997;
40
(11):
1300-6
-
From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM.
Oubré AY,
Carlson TJ, King SR, Reaven GM.
Diabetologia.
1997;
40
(5):
614-7
-
Growth hormone--ready for prime time?
Marcus R,
Reaven GM.
J Clin Endocrinol Metab.
1997;
82
(3):
725-6
-
Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers.
Wang PW,
Abbasi F, Carantoni M, Chen YD, Azhar S, Reaven GM.
J Clin Endocrinol Metab.
1997;
82
(10):
3221-4
-
Much ado about (almost) nothing.
Coulston AM,
Reaven GM.
Diabetes Care.
1997;
20
(3):
241-3
-
Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
Abbasi F,
Kamath V, Rizvi AA, Carantoni M, Chen YD, Reaven GM.
Diabetes Care.
1997;
20
(12):
1863-9
-
The kidney: an unwilling accomplice in syndrome X.
Reaven GM,
Am J Kidney Dis.
1997;
30
(6):
928-31
-
Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population.
Zavaroni I,
Bonini L, Gasparini P, Zuccarelli A, Dall'Aglio E, Barilli L, Cioni F, Strata A, Reaven GM.
J Intern Med.
1996;
240
(3):
151-6
-
Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate.
Facchini FS,
Stoohs RA, Reaven GM.
Am J Hypertens.
1996;
9
(10 Pt 1):
1013-7
-
Gemfibrozil treatment of endogenous hypertriglyceridemia: effect on insulin-mediated glucose disposal and plasma insulin concentrations.
Jeng CY,
Sheu WH, Fuh MM, Shieh SM, Chen YD, Reaven GM.
J Clin Endocrinol Metab.
1996;
81
(7):
2550-3
-
Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.
Reaven GM,
Lithell H, Landsberg L.
N Engl J Med.
1996;
334
(6):
374-81
-
Insulin resistance in patients with essential hypertension can occur in the absence of microalbuminuria.
Yip JW,
Jones C, Facchini F, Chen I, Reaven GM.
Am J Hypertens.
1996;
9
(10 Pt 1):
959-63
-
Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit?
Reaven GM,
Chen YD.
Circulation.
1996;
93
(10):
1780-3
-
Lack of a relationship between urinary albumin excretion rate and insulin resistance in patients with non-insulin-dependent diabetes mellitus.
Rizvi A,
Varasteh B, Chen YD, Reaven GM.
Metabolism.
1996;
45
(9):
1062-4
-
Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22.
Wu DA,
Bu X, Warden CH, Shen DD, Jeng CY, Sheu WH, Fuh MM, Katsuya T, Dzau VJ, Reaven GM, Lusis AJ, Rotter JI, Chen YD.
J Clin Invest.
1996;
97
(9):
2111-8
-
Relation between dietary vitamin intake and resistance to insulin-mediated glucose disposal in healthy volunteers.
Facchini F,
Coulston AM, Reaven GM.
Am J Clin Nutr.
1996;
63
(6):
946-9
-
Resistance to insulin-mediated glucose disposal in patients with noninsulin-dependent diabetes mellitus in the absence of obesity or microalbuminuria--a Clinical Research Center study.
Sheu W,
Jeng CY, Fuh M, Chen YD, Reaven GM.
J Clin Endocrinol Metab.
1996;
81
(3):
1156-9
-
Are insulin resistance and/or compensatory hyperinsulinemia involved in the etiology and clinical course of patients with hypertension?
Reaven GM,
Int J Obes Relat Metab Disord.
1995:
19 Suppl 1
S2-5
-
Association between salt sensitivity and insulin concentrations in patients with hypertension.
Zavaroni I,
Coruzzi P, Bonini L, Mossini GL, Musiari L, Gasparini P, Fantuzzi M, Reaven GM.
Am J Hypertens.
1995;
8
(8):
855-8
-
Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes.
Santos RF,
Nomizo R, Wajhenberg BL, Reaven GM, Azhar S.
Diabete Metab.
1995;
21
(4):
274-80
-
Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure.
Reaven GM,
Clinkingbeard C, Jeppesen J, Maheux P, Pei D, Foote J, Hollenbeck CB, Chen YD.
Am J Hypertens.
1995;
8
(5 Pt 1):
461-6
-
Comparison of the metabolic changes in rats with hypertension secondary to fructose feeding or renal artery stenosis.
Dall'Aglio E,
Tosini P, Zavaroni I, Olivetti G, Reaven GM.
Am J Hypertens.
1995;
8
(5 Pt 1):
524-7
-
Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
Sheu WH,
Jeng CY, Fuh MM, Chen YD, Reaven GM.
Diabetes Care.
1995;
18
(12):
1582-7
-
Effect of metformin on various aspects of glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus with varying degrees of hyperglycemia.
Reaven GM,
Diabetes Metab Rev.
1995:
11 Suppl 1
S97-108
-
Effect of variations in oral fat and carbohydrate load on postprandial lipemia.
Jeppesen J,
Chen YD, Zhou MY, Wang T, Reaven GM.
Am J Clin Nutr.
1995;
62
(6):
1201-5
-
Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals.
Su HY,
Sheu WH, Chin HM, Jeng CY, Chen YD, Reaven GM.
Am J Hypertens.
1995;
8
(11):
1067-71
-
Effects of low sodium diet and unilateral nephrectomy on the development of carbohydrate-induced hypertension.
Donnelly R,
Ho H, Reaven GM.
Blood Press.
1995;
4
(3):
164-9
-
Pathophysiology of insulin resistance in human disease.
Reaven GM,
Physiol Rev.
1995;
75
(3):
473-86
-
Postprandial triglyceride and retinyl ester responses to oral fat: effects of fructose.
Jeppesen J,
Chen YI, Zhou MY, Schaaf P, Coulston A, Reaven GM.
Am J Clin Nutr.
1995;
61
(4):
787-91
-
Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
Jeppesen J,
Hollenbeck CB, Zhou MY, Coulston AM, Jones C, Chen YD, Reaven GM.
Arterioscler Thromb Vasc Biol.
1995;
15
(3):
320-4
-
Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia.
Katsuya T,
Horiuchi M, Chen YD, Koike G, Pratt RE, Dzau VJ, Reaven GM.
Arterioscler Thromb Vasc Biol.
1995;
15
(6):
779-82
-
Relationship between insulin-mediated glucose disposal by muscle and adipose tissue lipolysis in healthy volunteers.
Pei D,
Chen YD, Hollenbeck CB, Bhargava R, Reaven GM.
J Clin Endocrinol Metab.
1995;
80
(11):
3368-72
-
Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy.
Fuh MM,
Yin CS, Pei D, Sheu WH, Jeng CY, Chen YI, Reaven GM.
Am J Hypertens.
1995;
8
(7):
768-71
-
The fourth musketeer--from Alexandre Dumas to Claude Bernard.
Reaven GM,
Diabetologia.
1995;
38
(1):
3-13
-
Tissue-dependent activation of protein kinase C in fructose-induced insulin resistance.
Donnelly R,
Chang H, Azhar S, Reaven GM.
Endocrine.
1995;
3
(2):
129-33
-
Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM?
Chen YD,
Coulston AM, Zhou MY, Hollenbeck CB, Reaven GM.
Diabetes Care.
1995;
18
(1):
10-6
-
Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance.
Maheux P,
Jeppesen J, Sheu WH, Hollenbeck CB, Clinkingbeard C, Greenfield MS, Chen YD, Reaven GM.
Hypertension.
1994;
24
(6):
695-8
-
Changes in glucose, insulin, lipid, lipoprotein, and apoprotein concentrations and insulin action in doxazosin-treated patients with hypertension. Comparison between nondiabetic individuals and patients with non-insulin-dependent diabetes mellitus.
Maheux P,
Facchini F, Jeppesen J, Greenfield MS, Clinkingbeard C, Chen YD, Reaven GM.
Am J Hypertens.
1994;
7
(5):
416-24
-
Effect of glipizide treatment on postprandial lipaemia in patients with NIDDM.
Jeppesen J,
Zhou MY, Chen YD, Reaven GM.
Diabetologia.
1994;
37
(8):
781-7
-
Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.
Jeppesen J,
Zhou MY, Chen YD, Reaven GM.
Diabetes Care.
1994;
17
(10):
1093-9
-
Effects of gemfibrozil on triglyceride metabolism in Dahl salt-sensitive rats.
Donnelly R,
Plato PA, Chang H, Reaven GM.
J Pharmacol Exp Ther.
1994;
270
(2):
809-13
-
Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test.
Pei D,
Jones CN, Bhargava R, Chen YD, Reaven GM.
Diabetologia.
1994;
37
(8):
843-5
-
Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance.
Donnelly R,
Reed MJ, Azhar S, Reaven GM.
Endocrinology.
1994;
135
(6):
2369-74
-
Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic.
Reaven GM,
Mondon CE, Chen YD, Breslow JL.
J Lipid Res.
1994;
35
(5):
820-4
-
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.
Reaven GM,
Laws A.
Diabetologia.
1994;
37
(9):
948-52
-
Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity.
Facchini F,
Chen YD, Reaven GM.
Diabetes Care.
1994;
17
(2):
115-9
-
Metabolic risk factors for atherosclerosis in heart transplant recipients.
Kemna MS,
Valantine HA, Hunt SA, Schroeder JS, Chen YD, Reaven GM.
Am Heart J.
1994;
128
(1):
68-72
-
Nutritional status modifies insulin-mediated glucose uptake in spontaneously hypertensive rats.
Plato PA,
Mondon CE, Reaven GM.
Blood Press.
1994;
3
(5):
336-9
-
Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.
Jeng CY,
Sheu WH, Fuh MM, Chen YD, Reaven GM.
Diabetes.
1994;
43
(12):
1440-4
-
Resistance to insulin-stimulated glucose uptake and dyslipidemia in Asian Indians.
Laws A,
Jeppesen JL, Maheux PC, Schaaf P, Chen YD, Reaven GM.
Arterioscler Thromb.
1994;
14
(6):
917-22
-
Salt-sensitive and carbohydrate-sensitive rodent hypertension: evidence of strain differences.
Reed MJ,
Ho H, Donnelly R, Reaven GM.
Blood Press.
1994;
3
(3):
197-201
-
Syndrome X: 6 years later.
Reaven GM,
J Intern Med Suppl.
1994:
736
13-22
-
Plasma lactate concentration in obesity and type 2 diabetes.
Chen YD,
Varasteh BB, Reaven GM.
Diabete Metab.
1993 Jul-Aug;
19
(4):
348-54
-
Are triglycerides important as a risk factor for coronary disease?
Reaven GM,
Heart Dis Stroke.
1993 Jan-Feb;
2
(1):
44-8
-
Clinical review 43: Treatment of hypertension: focus on prevention of coronary heart disease.
Reaven GM,
J Clin Endocrinol Metab.
1993;
76
(3):
537-40
-
Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
Chen YD,
Swami S, Skowronski R, Coulston A, Reaven GM.
J Clin Endocrinol Metab.
1993;
76
(1):
172-7
-
Effect of variations in dietary fat and carbohydrate intake on postprandial lipemia in patients with noninsulin dependent diabetes mellitus.
Chen YD,
Swami S, Skowronski R, Coulston AM, Reaven GM.
J Clin Endocrinol Metab.
1993;
76
(2):
347-51
-
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.
Reaven GM,
Chen YD, Jeppesen J, Maheux P, Krauss RM.
J Clin Invest.
1993;
92
(1):
141-6
-
Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals.
Reaven GM,
Brand RJ, Chen YD, Mathur AK, Goldfine I.
Diabetes.
1993;
42
(9):
1324-32
-
Insulin resistance and risk factors for coronary heart disease.
Laws A,
Reaven GM.
Baillieres Clin Endocrinol Metab.
1993;
7
(4):
1063-78
-
Metabolic and behavioral covariates of high-density lipoprotein cholesterol and triglyceride concentrations in postmenopausal women.
Laws A,
King AC, Haskell WL, Reaven GM.
J Am Geriatr Soc.
1993;
41
(12):
1289-94
-
Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM,
Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS.
J Clin Endocrinol Metab.
1993;
76
(1):
44-8
-
Role of insulin resistance in human disease (syndrome X): an expanded definition.
Reaven GM,
Annu Rev Med.
1993:
44
121-31
-
Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus.
Reaven GM,
Diabetes Metab Rev.
1993:
9 Suppl 1
5S-12S
-
Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus.
Gradman TJ,
Laws A, Thompson LW, Reaven GM.
J Am Geriatr Soc.
1993;
41
(12):
1305-12
-
Why does insulin resistance develop during maturation?
Reed MJ,
Reaven GM, Mondon CE, Azhar S.
J Gerontol.
1993;
48
(4):
B139-44
-
Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
Reaven GM,
Johnston P, Hollenbeck CB, Skowronski R, Zhang JC, Goldfine ID, Chen YD.
J Clin Endocrinol Metab.
1992;
74
(5):
1020-6
-
Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women.
Facchini F,
Hollenbeck CB, Chen YN, Chen YD, Reaven GM.
J Intern Med.
1992;
232
(3):
267-72
-
Effect of acute variations in dietary fat and carbohydrate intake on retinyl ester content of intestinally derived lipoproteins.
Chen YD,
Skowronski R, Coulston AM, Pietarinen J, Hollenbeck CB, Reaven GM.
J Clin Endocrinol Metab.
1992;
74
(1):
28-32
-
Effect of nicotinic acid on plasma glucose concentration in normal individuals.
Landau C,
Chen YD, Skowronski R, Hollenbeck CB, Jaspan JB, Reaven GM.
Horm Metab Res.
1992;
24
(9):
424-8
-
Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations.
Laws A,
Reaven GM.
J Intern Med.
1992;
231
(1):
25-30
-
Glucose, insulin, and lipid metabolism in doxazosin-treated patients with hypertension.
Shieh SM,
Sheu WH, Shen DC, Fuh MM, Chen YD, Reaven GM.
Am J Hypertens.
1992;
5
(11):
827-31
-
Insulin resistance and cigarette smoking.
Facchini FS,
Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM.
Lancet.
1992;
339
(8802):
1128-30
-
Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension.
Facchini F,
Chen YD, Clinkingbeard C, Jeppesen J, Reaven GM.
Am J Hypertens.
1992;
5
(10):
694-9
-
Lactate production and pyruvate dehydrogenase activity in fat and skeletal muscle from diabetic rats.
Mondon CE,
Jones IR, Azhar S, Hollenbeck CB, Reaven GM.
Diabetes.
1992;
41
(12):
1547-54
-
Renal vascular hypertension does not lead to hyperinsulinemia in Sprague-Dawley rats.
Reaven GM,
Ho H.
Am J Hypertens.
1992;
5
(5 Pt 1):
314-7
-
Syndrome X.
Reaven GM,
Blood Press Suppl.
1992:
4
13-6
-
The role of insulin resistance and hyperinsulinemia in coronary heart disease.
Reaven GM,
Metabolism.
1992;
41
(5 Suppl 1):
16-9
-
Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB,
Johnston P, Varasteh BB, Chen YD, Reaven GM.
Diabete Metab.
1991 Sep-Oct;
17
(5):
483-9
-
Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men.
Laws A,
King AC, Haskell WL, Reaven GM.
Arterioscler Thromb.
1991 Nov-Dec;
11
(6):
1636-42
-
Abnormalities of carbohydrate and lipid metabolism in Dahl rats.
Reaven GM,
Twersky J, Chang H.
Hypertension.
1991;
18
(5):
630-5
-
Abnormalities of carbohydrate and lipoprotein metabolism in patients with hypertension. Relationship to obesity.
Reaven GM,
Ann Epidemiol.
1991;
1
(4):
305-11
-
Age-associated differences in beta adrenergic-stimulated lipolysis in adipocytes from Sprague-Dawley and Fischer 344 rats.
Twersky J,
Hoffman BB, Reaven GM.
J Gerontol.
1991;
46
(4):
B125-9
-
Changes in carbohydrate metabolism in association with glipizide treatment of type 2 diabetes.
Jeng CY,
Hollenbeck CB, Wu MS, Foley JE, Chen YD, Reaven GM.
Diabet Med.
1991;
8
(1):
32-9
-
Characterization of insulin receptor kinase activity and autophosphorylation in different skeletal muscle types.
Azhar S,
Butte JC, Santos RF, Mondon CE, Reaven GM.
Am J Physiol.
1991;
260
(1 Pt 1):
E1-7
-
Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension.
Sheu WH,
Swislocki AL, Hoffman B, Chen YD, Reaven GM.
Am J Hypertens.
1991;
4
(3 Pt 1):
199-205
-
Differences in insulin action as a function of original anatomical site of newly differentiated adipocytes obtained in primary culture.
Sztalryd C,
Azhar S, Reaven GM.
J Clin Invest.
1991;
88
(5):
1629-35
-
High density lipoprotein turnover in patients with hypertension.
Chen YD,
Sheu WH, Swislocki AL, Reaven GM.
Hypertension.
1991;
17
(3):
386-93
-
Hypertriglyceridemia in Dahl rats: effect of sodium intake and gender.
Reaven GM,
Twersky J, Ho H, Chang H.
Horm Metab Res.
1991;
23
(1):
44-5
-
Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease.
Reaven GM,
Am Heart J.
1991;
121
(4 Pt 2):
1283-8
-
Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension.
Reaven GM,
Am J Med.
1991;
90
(2A):
7S-12S
-
Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models.
Reaven GM,
Diabetes Care.
1991;
14
(3):
195-202
-
Intestinally-derived lipoproteins: metabolism and clinical significance.
Chen YD,
Reaven GM.
Diabetes Metab Rev.
1991;
7
(3):
191-208
-
Low-dose streptozotocin-induced diabetes in the spontaneously hypertensive rat.
Reaven GM,
Ho H.
Metabolism.
1991;
40
(4):
335-7
-
Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes.
Skowronski R,
Hollenbeck CB, Varasteh BB, Chen YD, Reaven GM.
Diabet Med.
1991;
8
(4):
330-3
-
Relationship between insulin resistance and hypertension.
Reaven GM,
Diabetes Care.
1991:
14 Suppl 4
33-8
-
Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.
Facchini F,
Chen YD, Hollenbeck CB, Reaven GM.
JAMA.
1991;
266
(21):
3008-11
-
Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in non-insulin-dependent diabetes, high blood pressure, dyslipidemia and coronary heart disease.
Reaven GM,
Diabete Metab.
1991;
17
(1 Pt 2):
78-86
-
Sugar-induced hypertension in Sprague-Dawley rats.
Reaven GM,
Ho H.
Am J Hypertens.
1991;
4
(7 Pt 1):
610-4
-
Acute changes in plasma non-esterified fatty acid concentration do not change hepatic glucose production in people with type 2 diabetes.
Johnston P,
Hollenbeck C, Sheu W, Chen YD, Reaven GM.
Diabet Med.
1990;
7
(10):
871-5
-
Dietary management of nursing home residents with non-insulin-dependent diabetes mellitus.
Coulston AM,
Mandelbaum D, Reaven GM.
Am J Clin Nutr.
1990;
51
(1):
67-71
-
Differences in insulin-induced glucose uptake and enzyme activity in running rats.
Rodnick KJ,
Mondon CE, Haskell WL, Azhar S, Reaven GM.
J Appl Physiol.
1990;
68
(2):
513-9
-
Does glucagon increase plasma free fatty acid concentration in humans with normal glucose tolerance?
Wu MS,
Jeng CY, Hollenbeck CB, Chen YD, Jaspan J, Reaven GM.
J Clin Endocrinol Metab.
1990;
70
(2):
410-6
-
Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.
Reaven GM,
Lardinois CK, Greenfield MS, Schwartz HC, Vreman HJ.
Diabetes Care.
1990:
13 Suppl 3
32-6
-
Effect of central obesity on regulation of carbohydrate metabolism in obese patients with varying degrees of glucose tolerance.
Golay A,
Chen N, Chen YD, Hollenbeck C, Reaven GM.
J Clin Endocrinol Metab.
1990;
71
(5):
1299-304
-
Effect of chronic renal failure on high-density lipoprotein kinetics.
Fuh MM,
Lee CM, Jeng CY, Shen DC, Shieh SM, Reaven GM, Chen YD.
Kidney Int.
1990;
37
(5):
1295-300
-
Effect of difference in glucose infusion rate on quantification of hepatic glucose production.
Sheu WH,
Hollenbeck CB, Wu MS, Jaspan JB, Chen YD, Reaven GM.
J Clin Endocrinol Metab.
1990;
70
(5):
1354-60
-
Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.
Wu MS,
Johnston P, Sheu WH, Hollenbeck CB, Jeng CY, Goldfine ID, Chen YD, Reaven GM.
Diabetes Care.
1990;
13
(1):
1-8
-
Effect of prazosin treatment on HDL kinetics in patients with hypertension.
Sheu WH,
Swislocki AL, Hoffman BB, Reaven GM, Chen YD.
Am J Hypertens.
1990;
3
(10):
761-8
-
Effects of a fructose-enriched diet on plasma insulin and triglyceride concentration in SHR and WKY rats.
Reaven GM,
Ho H, Hoffman BB.
Horm Metab Res.
1990;
22
(7):
363-5
-
Effects of insulin on carbohydrate and protein metabolism in voluntary running rats.
Rodnick KJ,
Reaven GM, Azhar S, Goodman MN, Mondon CE.
Am J Physiol.
1990;
259
(5 Pt 1):
E706-14
-
Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes.
Kjaer M,
Hollenbeck CB, Frey-Hewitt B, Galbo H, Haskell W, Reaven GM.
J Appl Physiol.
1990;
68
(5):
2067-74
-
Insulin and hypertension.
Reaven GM,
Clin Exp Hypertens A.
1990;
12
(5):
803-16
-
Relationship between hyperglycemia and cognitive function in older NIDDM patients.
Reaven GM,
Thompson LW, Nahum D, Haskins E.
Diabetes Care.
1990;
13
(1):
16-21
-
Role of abnormalities of carbohydrate and lipoprotein metabolism in the pathogenesis and clinical course of hypertension.
Reaven GM,
J Cardiovasc Pharmacol.
1990:
15 Suppl 5
S4-7
-
How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes?
Jeng CY,
Hollenbeck CB, Wu MS, Chen YD, Reaven GM.
Diabet Med.
1989 May-Jun;
6
(4):
303-8
-
Abnormal insulin metabolism by specific organs from rats with spontaneous hypertension.
Mondon CE,
Reaven GM, Azhar S, Lee CM, Rabkin R.
Am J Physiol.
1989;
257
(4 Pt 1):
E491-8
-
Cellular tolerance to adenosine receptor-mediated inhibition of lipolysis: altered adenosine 3',5'-monophosphate metabolism and protein kinase activation.
Hoffman BB,
Prokocimer P, Thomas JM, Vagelos R, Chang H, Reaven GM.
Endocrinology.
1989;
124
(5):
2434-42
-
Effect of age on glucose tolerance and glucose uptake in healthy individuals.
Reaven GM,
Chen N, Hollenbeck C, Chen YD.
J Am Geriatr Soc.
1989;
37
(8):
735-40
-
Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension.
Swislocki AL,
Hoffman BB, Sheu WH, Chen YD, Reaven GM.
Am J Med.
1989;
86
(1B):
14-8
-
Effects of exercise training on the relationship between insulin binding and insulin-stimulated tyrosine kinase activity in rat skeletal muscle.
Santos RF,
Mondon CE, Reaven GM, Azhar S.
Metabolism.
1989;
38
(4):
376-86
-
Effects of sucrose on carbohydrate and lipid metabolism in NIDDM patients.
Hollenbeck CB,
Coulston AM, Reaven GM.
Diabetes Care.
1989;
12
(1):
62-6; discussion 81-2
-
Hypertension as a disease of carbohydrate and lipoprotein metabolism.
Reaven GM,
Hoffman BB.
Am J Med.
1989;
87
(6A):
2S-6S
-
Impaired insulin-mediated inhibition of lipolysis and glucose transport with aging.
Reaven GM,
Chang H, Hoffman BB.
Horm Metab Res.
1989;
21
(4):
168-71
-
Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus.
Laws A,
Stefanick ML, Reaven GM.
J Clin Endocrinol Metab.
1989;
69
(2):
343-7
-
Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension.
Swislocki AL,
Hoffman BB, Reaven GM.
Am J Hypertens.
1989;
2
(6 Pt 1):
419-23
-
Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients.
Coulston AM,
Hollenbeck CB, Swislocki AL, Reaven GM.
Diabetes Care.
1989;
12
(2):
94-101
-
Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance.
Reaven GM,
Hollenbeck CB, Chen YD.
Diabetologia.
1989;
32
(1):
52-5
-
Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats.
Reaven GM,
Chang H, Hoffman BB, Azhar S.
Diabetes.
1989;
38
(9):
1155-60
-
Somatostatin inhibition of fructose-induced hypertension.
Reaven GM,
Ho H, Hoffmann BB.
Hypertension.
1989;
14
(2):
117-20
-
The combined use of insulin and sulfonylurea therapy in patients with non-insulin dependent diabetes mellitus.
Reaven GM,
Fraze E, Chen NY, Hollenbeck C, Chen YD.
Horm Metab Res.
1989;
21
(3):
132-6
-
Variations in running activity and enzymatic adaptations in voluntary running rats.
Rodnick KJ,
Reaven GM, Haskell WL, Sims CR, Mondon CE.
J Appl Physiol.
1989;
66
(3):
1250-7
-
Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes.
Reaven GM,
Chang H, Hoffman BB.
Diabetes.
1988;
37
(1):
28-32
-
Amino-terminal peptide of growth hormone enhances insulin action in normal rats.
Mondon CE,
Reaven GM, Ling N, Lewis UJ, Frigeri LG.
Endocrinology.
1988;
123
(2):
827-33
-
Attenuation of fructose-induced hypertension in rats by exercise training.
Reaven GM,
Ho H, Hoffman BB.
Hypertension.
1988;
12
(2):
129-32
-
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven GM,
Diabetes.
1988;
37
(12):
1595-607
-
Comparison of plasma glucose and insulin responses to mixed meals of high-, intermediate-, and low-glycemic potential.
Hollenbeck CB,
Coulston AM, Reaven GM.
Diabetes Care.
1988;
11
(4):
323-9
-
Effect of enprostil on plasma glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
Reaven GM,
Swislocki AL, Jeng CY, Hollenbeck CB, Schwartz K, Chen YD.
Horm Metab Res.
1988;
20
(10):
633-6
-
Effect of insulin deficiency on low density lipoprotein metabolism in rabbits.
Golay A,
Zech L, Shi MZ, Chiou YA, Reaven GM, Chen YD.
Horm Metab Res.
1988;
20
(1):
11-4
-
Effect of time on measurement of hepatic glucose production.
Chen YD,
Swislocki AL, Jeng CY, Juang JH, Reaven GM.
J Clin Endocrinol Metab.
1988;
67
(5):
1084-8
-
Evidence for age-related changes in pyridine nucleotide content of isolated rat islets.
Azhar S,
Ho HY, Reaven E, Reaven GM.
Horm Metab Res.
1988;
20
(9):
559-61
-
Evidence of a defect in insulin-receptor recycling in adipocytes from older rats.
Trischitta V,
Reaven GM.
Am J Physiol.
1988;
254
(1 Pt 1):
E39-44
-
Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension.
Mondon CE,
Reaven GM.
Metabolism.
1988;
37
(4):
303-5
-
Insulin secretion and insulin action in Taiwanese with type 2 diabetes.
Shen DC,
Kuo SW, Shian LR, Fuh MT, Wu DA, Chen YD, Reaven GM.
Diabetes Res Clin Pract.
1988;
4
(4):
289-93
-
Lowering of plasma glucose in diabetic rats by antilipolytic agents.
Reaven GM,
Chang H, Ho H, Jeng CY, Hoffman BB.
Am J Physiol.
1988;
254
(1 Pt 1):
E23-30
-
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.
Reaven GM,
Hollenbeck C, Jeng CY, Wu MS, Chen YD.
Diabetes.
1988;
37
(8):
1020-4
-
Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes.
Chen YD,
Jeng CY, Hollenbeck CB, Wu MS, Reaven GM.
J Clin Invest.
1988;
82
(1):
21-5
-
Resistance to insulin-stimulated-glucose uptake in patients with hypertension.
Shen DC,
Shieh SM, Fuh MM, Wu DA, Chen YD, Reaven GM.
J Clin Endocrinol Metab.
1988;
66
(3):
580-3
-
Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus.
Reaven GM,
Chen YD.
Am J Med.
1988;
85
(5A):
106-12
-
Role of insulin in regulation of lipoprotein metabolism in diabetes.
Reaven GM,
Chen YD.
Diabetes Metab Rev.
1988;
4
(7):
639-52
-
Effect of age and sex on rat endocrine pancreas.
Reaven EP,
Curry DL, Reaven GM.
Diabetes.
1987;
36
(12):
1397-400
-
Fructose-induced insulin resistance and hypertension in rats.
Hwang IS,
Ho H, Hoffman BB, Reaven GM.
Hypertension.
1987;
10
(5):
512-6
-
Improved insulin action in muscle, liver, and adipose tissue in physically trained human subjects.
Rodnick KJ,
Haskell WL, Swislocki AL, Foley JE, Reaven GM.
Am J Physiol.
1987;
253
(5 Pt 1):
E489-95
-
Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes.
Swislocki AL,
Chen YD, Golay A, Chang MO, Reaven GM.
Diabetologia.
1987;
30
(8):
622-6
-
Stimulation and inhibition of lipolysis in isolated rat adipocytes: evidence for age-related changes in responses to forskolin and PGE1.
Hoffman BB,
Chang H, Reaven GM.
Horm Metab Res.
1987;
19
(8):
358-60
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help